Get the Stockscreener App
29.70
8.00%
2.20
Pre-market:
29.49
-0.21
-0.71%
Caris Life Sciences Inc stock is traded at $29.70, with a volume of 5.03M.
It is up +8.00% in the last 24 hours and up +22.02% over the past month.
Caris Life Sciences Inc is a patient-centric, next-generation AI TechBio company. It develop and commercialize solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale.
See More
Previous Close:
$27.50
Open:
$27.82
24h Volume:
5.03M
Relative Volume:
1.21
Market Cap:
$8.39B
Revenue:
$907.29M
Net Income/Loss:
$33.98M
P/E Ratio:
-20.27
EPS:
-1.4655
Net Cash Flow:
$115.75M
1W Performance:
-2.27%
1M Performance:
+22.02%
6M Performance:
+64.54%
1Y Performance:
-2.56%
1-Day Range:
$0.00
$0.00
1-Week Range:
$25.87
$32.56
52-Week Range:
$14.19
$33.65
Caris Life Sciences Inc Stock (CAI) Company Profile
Name
Caris Life Sciences Inc
Sector
Industry
Phone
(866) 771-8946
Address
750 W JOHN CARPENTER FREEWAY, IRVING
Compare CAI vs VRTX, MRNA, REGN, ARGX, RVMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CAI
Caris Life Sciences Inc
|
29.70 | 8.39B | 907.29M | 33.98M | 115.75M | -1.4655 |
VRTX
Vertex Pharmaceuticals Inc
|
510.08 | 129.29B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
225.00 | 89.83B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
746.54 | 76.86B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
825.03 | 51.88B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
189.76 | 40.67B | 742.00K | -1.37B | -1.07B | -7.0731 |
Caris Life Sciences Inc Stock (CAI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-09-26 | Initiated | UBS | Neutral |
| Jun-02-26 | Resumed | Wolfe Research | Peer Perform |
| Apr-13-26 | Initiated | Jefferies | Buy |
| Apr-10-26 | Initiated | Piper Sandler | Neutral |
| Apr-01-26 | Initiated | Goldman | Buy |
| Feb-17-26 | Initiated | Robert W. Baird | Outperform |
| Dec-02-25 | Initiated | Canaccord Genuity | Hold |
| Jul-14-25 | Initiated | BTIG Research | Buy |
| Jul-14-25 | Initiated | BofA Securities | Buy |
| Jul-14-25 | Initiated | Citigroup | Buy |
| Jul-14-25 | Initiated | Evercore ISI | Outperform |
| Jul-14-25 | Initiated | Guggenheim | Buy |
| Jul-14-25 | Initiated | JP Morgan | Overweight |
| Jul-14-25 | Initiated | TD Cowen | Buy |
| Jul-14-25 | Initiated | Wolfe Research | Outperform |
| Jun-30-21 | Downgrade | Keefe Bruyette | Outperform → Mkt Perform |
| Jun-21-21 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jun-09-21 | Resumed | B. Riley Securities | Buy |
| Dec-09-20 | Initiated | B. Riley Securities | Buy |
| Oct-19-20 | Upgrade | Keefe Bruyette | Mkt Perform → Outperform |
| Jun-15-20 | Downgrade | Keefe Bruyette | Outperform → Mkt Perform |
| May-07-20 | Upgrade | Keefe Bruyette | Mkt Perform → Outperform |
| Nov-05-19 | Downgrade | Cowen | Outperform → Market Perform |
| Aug-08-19 | Reiterated | Cowen | Outperform |
| Feb-21-19 | Downgrade | Keefe Bruyette | Outperform → Mkt Perform |
| Oct-31-18 | Reiterated | Cowen | Outperform |
| Sep-28-18 | Downgrade | Wells Fargo | Outperform → Market Perform |
| Sep-07-18 | Upgrade | Keefe Bruyette | Mkt Perform → Outperform |
| Apr-24-18 | Initiated | Compass Point | Buy |
| Feb-15-18 | Reiterated | Cowen | Outperform |
| Feb-14-18 | Upgrade | Wells Fargo | Market Perform → Outperform |
| Oct-23-17 | Upgrade | Cowen | Market Perform → Outperform |
| Jul-27-17 | Reiterated | Cowen | Market Perform |
| Apr-21-17 | Reiterated | Cowen | Market Perform |
| May-04-16 | Reiterated | Cowen | Market Perform |
| Feb-17-16 | Reiterated | Cowen | Market Perform |
| Jan-15-16 | Resumed | Keefe Bruyette | Mkt Perform |
View All
Caris Life Sciences Inc Stock (CAI) Latest News
Caris Life Sciences (NasdaqGS:CAI) Stock Forecast & Analyst Predictions - Simply Wall Street
Form 4 Caris Life Sciences Inc For: 24 September By Investing.com - Investing.com Canada
Caris Life Sciences SVP Denton sells $238,626 in shares - Investing.com
Form 4 Caris Life Sciences Inc For: 24 September By Investing.com - Investing.com South Africa
Form 4 Caris Life Sciences Inc For: 24 September By Investing.com - Investing.com India
Form 4 Caris Life Sciences Inc For: 24 September By Investing.com - Investing.com UK
Insider at Caris Life Sciences (CAI) lines up stock sale - Stock Titan
Caris Life Sciences(CAI.US) Officer Sells US$12.13 Million in Common Stock - Moomoo
Caris Life Sciences vice chairman Brille sells $12.1 million shares By Investing.com - Investing.com UK
Caris Life Sciences (CAI) director plans 400,000-share sale - Stock Titan
Caris Life Sciences vice chairman Brille sells $12.1 million shares - Investing.com
New investor pitch from Caris Life Sciences (CAI) set for Morgan Stanley healthcare event - Stock Titan
UBS Group Upgrades Caris Life Sciences (NASDAQ:CAI) to "Hold" - MarketBeat
Amundi Buys 1,197,392 Shares of Caris Life Sciences, Inc. $CAI - MarketBeat
Squarepoint Ops LLC Acquires Shares of 380,927 Caris Life Sciences, Inc. $CAI - MarketBeat
Menlo Advisors LLC Acquires Shares of 300,518 Caris Life Sciences, Inc. $CAI - MarketBeat
UBS Initiates Coverage on Caris Life Sciences With Neutral Rating, $28 Price Target - marketscreener.com
Caris Life Sciences launches national campaign with Kevin Costner to promote early cancer detection test Caris Detect. - Pluang
Caris Life Sciences Launches New National Commercial Featuring Kevin Costner to Raise Awareness of Early Cancer Detection and Caris Detect - PR Newswire
Could Caris Life Sciences (CAI) Be 7% Undervalued After Its Lung Cancer Research Update? - Yahoo Finance
47,595 Shares in Caris Life Sciences, Inc. $CAI Acquired by The Manufacturers Life Insurance Company - MarketBeat
Caris Life Sciences (CAI) Will Present Seven Studies At A Global Lung Conference - Yahoo Finance
Bank of New York Mellon Corp Takes Position in Caris Life Sciences, Inc. $CAI - MarketBeat
David Baxley Spetzler Sells 478,000 Shares of Caris Life Sciences (NASDAQ:CAI) Stock - MarketBeat
Insider Selling: Caris Life Sciences (NASDAQ:CAI) President Sells 119,212 Shares of Stock - MarketBeat
President Spetzler sells $14.8m in Caris Life Sciences stock By Investing.com - Investing.com Nigeria
President Spetzler sells $14.8m in Caris Life Sciences stock By Investing.com - Investing.com South Africa
President Spetzler sells $14.8m in Caris Life Sciences stock By Investing.com - Investing.com Australia
President Spetzler sells $14.8m in Caris Life Sciences stock - Investing.com India
President Spetzler sells $14.8m in Caris Life Sciences stock - investing.com
President Spetzler sells $14.8m in Caris Life Sciences stock - Investing.com
After an $11.9M stock sale, Caris Life Sciences (NYSE: CAI) holder plans another - Stock Titan
President Spetzler sells $14.8m in Caris Life Sciences stock By Investing.com - Investing.com Canada
Insider at Caris Life Sciences (CAI) lines up 2026 stock sale tied to expiring options - Stock Titan
Braidwell LP Purchases 246,585 Shares of Caris Life Sciences, Inc. $CAI - MarketBeat
Caris Life Sciences to Present New Research Advancing Precision Oncology at the IASLC 2026 World Conference on Lung Cancer - Morningstar
Caris Life Sciences to Present New Research Advancing Precision Oncology at the IASLC 2026 World Conference on Lung Cancer - PR Newswire
Moore Capital Management LP Makes New Investment in Caris Life Sciences, Inc. $CAI - MarketBeat
Deutsche Bank AG Purchases New Position in Caris Life Sciences, Inc. $CAI - MarketBeat
BlackRock Inc. Acquires New Stake in Caris Life Sciences, Inc. $CAI - MarketBeat
Caris Life Sciences, Inc. (NASDAQ:CAI) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Canada Pension Plan Investment Board Purchases Shares of 1,374,952 Caris Life Sciences, Inc. $CAI - MarketBeat
Caris Life Sciences Publishes npj Precision Oncology Study Showing AI-Guided Therapy Selection is Predictive of Longer Survival in Patients with Pancreatic Cancer - sahmcapital.com
Caris Life Sciences Publishes npj Precision Oncology Study Showing AI-Guided Therapy Selection is Predictive of Longer Survival in Patients with Pancreatic Cancer - PR Newswire
PointState Capital LP Makes New Investment in Caris Life Sciences, Inc. $CAI - MarketBeat
Caris Life Sciences (NASDAQ:CAI) Trading Down 6.2%What's Next? - marketbeat.com
Bank of America Corp DE Lowers Stake in Caris Life Sciences, Inc. $CAI - MarketBeat
Caris Life Sciences Stock Is Up 65% in Three Months, But Its Valuation Multiple Just Got Cheaper. - TIKR.com
Caris Life Sciences (NASDAQ: CAI) trust plans another stock sale - Stock Titan
Mitsubishi UFJ Asset Management Co. Ltd. Invests $1.52 Million in Caris Life Sciences, Inc. $CAI - MarketBeat
Caris Life Sciences Inc Stock (CAI) Financials Data
Revenue
Net Income
Cash Flow
EPS
Caris Life Sciences Inc Stock (CAI) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| JOHN RUSSEL DENTON | Officer |
Sep 22 '26 |
Proposed Sale |
31.82 |
7,500 |
238,626 |
0 |
| Brille Brian J | See Remarks |
Sep 17 '26 |
Sale |
30.33 |
400,000 |
12,132,080 |
230,303 |
| BRIAN J BRILLE | Officer |
Sep 17 '26 |
Proposed Sale |
30.33 |
400,000 |
12,132,080 |
0 |
| Brille Brian J | See Remarks |
Sep 17 '26 |
Option Exercise |
2.44 |
400,000 |
976,000 |
630,303 |
| DAVID SPETZLER | Officer |
Sep 04 '26 |
Proposed Sale |
24.76 |
119,212 |
2,951,117 |
0 |
| Spetzler David Baxley | President |
Sep 04 '26 |
Option Exercise |
2.44 |
250,000 |
610,000 |
1,302,083 |
| Spetzler David Baxley | President |
Sep 04 '26 |
Sale |
24.76 |
119,212 |
2,951,117 |
1,182,871 |
| Spetzler David Baxley | President |
Sep 03 '26 |
Option Exercise |
2.44 |
1,000,000 |
2,440,000 |
1,530,083 |
| DAVID SPETZLER | Officer |
Sep 03 '26 |
Proposed Sale |
24.86 |
478,000 |
11,882,984 |
0 |
| Spetzler David Baxley | President |
Sep 03 '26 |
Sale |
24.86 |
478,000 |
11,882,990 |
1,052,083 |
3.81%
1.02%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):